ASH 2021 – Hematological Adverse Event Management
Dr. Jerome Goldschmidt, MD, an oncologist at Blue Ridge Cancer Care discusses his poster presentation from the American Society of Hematology (ASH) 2021 Annual Meeting titled “Understanding Hematological Adverse Event Management through Health Care Resource Utilization, Costs, and Treatment Patterns of Patients with Extensive-Stage Small Cell Lung Cancer Treated in the Community Oncology Setting”
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Jerome Goldschmidt, MD, an oncologist at Blue Ridge Cancer Care discusses his poster presentation from the American Society of Hematology (ASH) 2021 Annual Meeting titled …
- Key Point: Jerome Goldschmidt obtained a bachelor of arts in German and a minor in chemistry from the University of North Carolina and is a graduate of the University of North Carolina Sch…
- Key Point: He completed his fellowship in medical oncology at the University of Rochester/Strong Memorial Hospital, Rochester, New York.
- Key Point: Goldschmidt has contributed to multiple publications and is a member of the American Society of Clinical Oncology.
- Key Point: He is board certified in medical oncology and internal medicine.
Dr. Jerome Goldschmidt obtained a bachelor of arts in German and a minor in chemistry from the University of North Carolina and is a graduate of the University of North Carolina School of Medicine. He completed his fellowship in medical oncology at the University of Rochester/Strong Memorial Hospital, Rochester, New York. Dr. Goldschmidt has contributed to multiple publications and is a member of the American Society of Clinical Oncology. He is board certified in medical oncology and internal medicine.
Dr. Goldschmidt’s interests are cancer survivorship, clinical research and cancer prevention. He also serves as adjunct faculty at Virginia College of Osteopathic Medicine.
In his spare time he enjoys spending time with his wife and children, reading and hiking.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



